The global surgical suture market size was valued at USD 4,919 million in 2024 and is expected to reach USD 7,430 million by 2034, growing at a CAGR of 4.21% from 2024 to 2034.
Surgical sutures are medical devices used by surgeons after surgery to stitch shut the wound or laceration by holding body tissues together. The application of sutures involves essentially a needle with an attached thread. Generally, surgeons prefer using either polypropylene or polydioxanone sutures for fascia, depending on how strong the repair is needed. Polypropylene is commonly used in cardiovascular surgery. The surgical suture market is driven by the rising prevalence of chronic and age-related diseases worldwide which require undergoing surgical procedures.
The surgical suture market is anticipated to witness a promising future with the introduction of robotic arms and barbed sutures. Currently, healthcare professionals prefer using sutures over staples and tapes. Moreover, the heavy investment noticed by the government for the development of the underdeveloped part of the healthcare facility to safeguard the population and bring a substantial amount of consumers to the market. Geographically, the Asia Pacific region is dominating the surgical suture market, especially in China and India. The existing medical advancement in China with the developing healthcare facilities such as non-invasive surgical methodologies for their residents offers an effective plus affordable way.
Published by Ajit Bansod
